22-Year-old patient with malignant hypertension associated with primary aldosteronism. 2013

A Prejbisz, and A Klisiewicz, and A Januszewicz, and J W Lenders, and B Pręgowska-Chwała, and K Jóźwik-Plebanek, and I Michałowska, and M Januszewicz, and P Andziak, and P Hoffman, and T J Guzik
Department of Hypertension, Institute of Cardiology, Warsaw, Poland. prejbisz@vp.pl

UI MeSH Term Description Entries
D006974 Hypertension, Malignant A condition of markedly elevated BLOOD PRESSURE with DIASTOLIC PRESSURE usually greater than 120 mm Hg. Malignant hypertension is characterized by widespread vascular damage, PAPILLEDEMA, retinopathy, HYPERTENSIVE ENCEPHALOPATHY, and renal dysfunction. Malignant Hypertension
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006929 Hyperaldosteronism A condition caused by the overproduction of ALDOSTERONE. It is characterized by sodium retention and potassium excretion with resultant HYPERTENSION and HYPOKALEMIA. Aldosteronism,Conn Syndrome,Conn's Syndrome,Primary Hyperaldosteronism,Conns Syndrome,Hyperaldosteronism, Primary,Syndrome, Conn,Syndrome, Conn's
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A Prejbisz, and A Klisiewicz, and A Januszewicz, and J W Lenders, and B Pręgowska-Chwała, and K Jóźwik-Plebanek, and I Michałowska, and M Januszewicz, and P Andziak, and P Hoffman, and T J Guzik
December 1963, The New England journal of medicine,
A Prejbisz, and A Klisiewicz, and A Januszewicz, and J W Lenders, and B Pręgowska-Chwała, and K Jóźwik-Plebanek, and I Michałowska, and M Januszewicz, and P Andziak, and P Hoffman, and T J Guzik
July 1960, Metabolism: clinical and experimental,
A Prejbisz, and A Klisiewicz, and A Januszewicz, and J W Lenders, and B Pręgowska-Chwała, and K Jóźwik-Plebanek, and I Michałowska, and M Januszewicz, and P Andziak, and P Hoffman, and T J Guzik
August 1966, The Journal of clinical endocrinology and metabolism,
A Prejbisz, and A Klisiewicz, and A Januszewicz, and J W Lenders, and B Pręgowska-Chwała, and K Jóźwik-Plebanek, and I Michałowska, and M Januszewicz, and P Andziak, and P Hoffman, and T J Guzik
July 1996, Blood pressure,
A Prejbisz, and A Klisiewicz, and A Januszewicz, and J W Lenders, and B Pręgowska-Chwała, and K Jóźwik-Plebanek, and I Michałowska, and M Januszewicz, and P Andziak, and P Hoffman, and T J Guzik
December 2022, Blood pressure,
A Prejbisz, and A Klisiewicz, and A Januszewicz, and J W Lenders, and B Pręgowska-Chwała, and K Jóźwik-Plebanek, and I Michałowska, and M Januszewicz, and P Andziak, and P Hoffman, and T J Guzik
January 1978, Wiadomosci lekarskie (Warsaw, Poland : 1960),
A Prejbisz, and A Klisiewicz, and A Januszewicz, and J W Lenders, and B Pręgowska-Chwała, and K Jóźwik-Plebanek, and I Michałowska, and M Januszewicz, and P Andziak, and P Hoffman, and T J Guzik
September 2023, Internal medicine (Tokyo, Japan),
A Prejbisz, and A Klisiewicz, and A Januszewicz, and J W Lenders, and B Pręgowska-Chwała, and K Jóźwik-Plebanek, and I Michałowska, and M Januszewicz, and P Andziak, and P Hoffman, and T J Guzik
October 1997, Internal medicine (Tokyo, Japan),
A Prejbisz, and A Klisiewicz, and A Januszewicz, and J W Lenders, and B Pręgowska-Chwała, and K Jóźwik-Plebanek, and I Michałowska, and M Januszewicz, and P Andziak, and P Hoffman, and T J Guzik
June 2020, Obstetric medicine,
A Prejbisz, and A Klisiewicz, and A Januszewicz, and J W Lenders, and B Pręgowska-Chwała, and K Jóźwik-Plebanek, and I Michałowska, and M Januszewicz, and P Andziak, and P Hoffman, and T J Guzik
July 2008, Journal of clinical pathology,
Copied contents to your clipboard!